Page 42 - CIBERDEM2016-ENG

leaD researcher
Bosch Tubert, Fátima
Universidad Autónoma de Barcelona
Centro de Biotecnología Animal y Terapia genética Edificio H - Campus UAB 08193 Bellaterra - Barcelona
(+34) 93 581 41 82 [email protected] group Website
gROUP MEMBERS
Staff members: Casellas Comallonga, Alba | Vilà Prats, Laia
Associated members: Barrero Victorio, Jennifer | Carretero Romay, Ana | Elias Puigdomenech, Ivet | Ferre Masferrer, María Del Tura | Franckhauser, Sylvie | García Martínez, Miguel | Haurigot, Virginia | Jiménez Cenzano, Verónica | León Madrenas, Xavier | Maggioni, Luca | Mallol Domínguez, Cristina | Melgarejo Bermúdez, Verónica | Molas Laplana, María | Morró Larrubia, Meritxell | Moya Martínez, Marta | Muñoz Forero, Sergio Antonio | Nacher García, Víctor | Navarro Beltrán, Marcos | Otaegui Goya, Pedro José | Pujol Altarriba, Anna | Ribera Sánchez, Albert | Roca Lecha, Carles | Ruberte Paris, Jesús | Zaguirre Sánchez, Mireia
Main lines of research
Study of causes and pathophysiological mechanisms of diabetes and obesity
• Study of the role of pancreatic ß cell alterations in the development of diabetes.
• Identification of novel genes in adipose tissue involved in the development of diabetes and obesity.
• Identification of novel mechanisms involved in browning of white adipose tissue. Development of new gene therapy approaches for diabetes
• Gene therapy approaches for the treatment of type 1 diabetes centered on genetic engineering of
skeletal muscle to produce insulin and/or increase glucose uptake.
• Gene therapy approaches for type 2 diabetes and obesity centered on genetic engineering of skeletal
muscle and/or the liver.
• Study of in vivo pancreas regeneration in diabetic animals:
Regeneration of endocrine pancreas by IgF-1
Betasel: in vivo selection of genes to improve beta cell mass
• Development of new approaches for type 2 diabetes and obesity centered on genetic engineering of
adipose tissue.
42
PROgRAMME
P2